Loading BIIB…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("BIIB","financials")Full statements spill as a table. For one cell: =jivedata("BIIB","Revenue") or =jivedata("BIIB","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
BIIB • CIK 0000875045
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenues | $9,835,600 | $9,675,900 | $9,890,600 | $9,937,400 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | $1,556,500 | $1,623,000 |
| Income Tax Expense (Benefit) | $135,300 | $273,800 | $263,600 | $251,100 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $1,161,500 | $1,632,200 | $1,292,900 | $1,371,900 |
| Net Income (Loss) Attributable to Noncontrolling Interest | $400 | $0 | $0 | $0 |
| Net Income (Loss) Attributable to Parent | $1,161,100 | $1,632,200 | $1,292,900 | $1,371,900 |
| Cost of Goods and Services Sold | $2,533,400 | $2,310,400 | $2,404,200 | $2,435,900 |
| Research and Development Expense (Excluding Acquired in Process Cost) | $2,462,000 | $2,041,800 | $1,778,600 | $1,883,500 |
| Selling, General and Administrative Expense | $2,549,700 | $2,403,700 | $2,433,600 | $2,468,400 |
| Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings | $0 | $-27,700 | $-33,600 | $-22,700 |
| Operating Lease, Impairment Loss | — | — | $52,900 | $52,900 |
| Restructuring Charges | $218,800 | $30,200 | $48,600 | $21,200 |
| Gain (Loss) on Disposition of Intangible Assets | — | $88,600 | $0 | $0 |
| Nonoperating Income (Expense) | $-315,500 | $-343,600 | $-305,600 | $-305,600 |
| Costs and Expenses | $8,538,800 | $7,769,900 | $8,334,100 | $8,314,400 |
| Weighted Average Number of Shares Outstanding, Basic | 144,700,000 | 145,600,000 | 146,500,000 | 147,600,000 |
| Weighted Average Number of Shares Outstanding, Diluted | 145,600,000 | 145,900,000 | 147,100,000 | 148,900,000 |
| Share-based Payment Arrangement, Expense | $-274,400 | $-301,500 | — | $-301,500 |
| Share-based Payment Arrangement, Expense, after Tax | $668,400 | $352,700 | $303,500 | $307,200 |
| Share-based Payment Arrangement, Amount Capitalized | $10,200 | $10,300 | $12,400 | $13,100 |
| Share-based Payment Arrangement, Expense, Tax Benefit | $132,600 | $63,400 | $57,000 | $57,500 |
| Weighted Average Number Diluted Shares Outstanding Adjustment | 900,000 | 300,000 | 600,000 | 1,300,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $1,049,900 | $2,375,000 | $3,008,500 | $3,382,700 |
| Debt Securities, Available-for-sale, Current | $0 | — | $807,200 | $900,000 |
| Debt Securities, Available-for-sale, Noncurrent | $0 | — | $431,900 | $465,600 |
| Accounts Receivable, after Allowance for Credit Loss, Current | $1,664,100 | $1,404,800 | $1,342,400 | $1,342,400 |
| Property, Plant and Equipment, Net | $3,309,700 | $3,181,300 | $3,055,400 | $3,017,900 |
| Operating Lease, Right-of-Use Asset | $420,000 | $356,400 | $265,400 | $251,300 |
| Inventory, Net | $2,527,400 | $2,460,500 | $2,168,100 | $1,949,000 |
| Intangible Assets, Net (Excluding Goodwill) | $8,363,000 | $9,691,200 | $9,178,500 | $9,053,500 |
| Other Assets, Current | $1,182,000 | $752,500 | $1,123,300 | $1,168,300 |
| Goodwill | $6,219,200 | $6,478,900 | $6,491,100 | $6,488,700 |
| Assets, Current | $6,859,300 | $7,456,800 | $8,974,100 | $9,190,400 |
| Deferred Income Tax Assets, Net | $928,600 | $324,200 | $292,500 | $238,200 |
| Other Assets, Noncurrent | $745,000 | $560,500 | $750,600 | $777,500 |
| Assets | $26,844,800 | $28,049,300 | $29,439,500 | $29,483,100 |
| Notes Payable, Noncurrent | $6,788,200 | $4,547,200 | $6,286,800 | $6,286,800 |
| Deferred Income Tax Liabilities, Net | $641,800 | $190,500 | $507,600 | $483,500 |
| Operating Lease, Liability, Noncurrent | $400,000 | $334,500 | $290,400 | $273,400 |
| Other Liabilities, Noncurrent | $781,100 | $732,300 | $748,500 | $787,100 |
| Liabilities | $12,045,400 | $11,333,300 | $11,182,700 | $10,831,400 |
| Debt, Current | $150,000 | $1,748,600 | $0 | $0 |
| Taxes Payable, Current | $257,400 | $548,300 | $114,800 | $93,600 |
| Accounts Payable, Current | $403,300 | $424,200 | $432,000 | $358,500 |
| Other Liabilities, Current | $2,623,600 | $2,807,700 | $2,802,600 | $2,546,800 |
| Liabilities, Current | $3,434,300 | $5,528,800 | $3,349,400 | $2,998,900 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $14,799,400 | $16,716,000 | $18,256,800 | $18,651,700 |
| Preferred Stock, Value, Outstanding | $0 | $0 | $0 | $0 |
| Common Stock, Value, Outstanding | $100 | $100 | $100 | $100 |
| Additional Paid in Capital | $302,500 | $569,400 | $863,100 | $896,700 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $-153,700 | $-136,200 | $-182,000 | $-140,200 |
| Retained Earnings (Accumulated Deficit) | $17,627,600 | $19,259,800 | $20,552,700 | $20,872,200 |
| Treasury Stock, Value | $2,977,100 | $2,977,100 | $2,977,100 | $2,977,100 |
| Accounts Receivable, Allowance for Credit Loss, Current | $2,400 | $2,200 | $3,000 | $3,000 |
| Treasury Stock, Common, Shares | 23,800,000 | 23,800,000 | 23,800,000 | 23,800,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | $-2,404,500 | $1,392,800 | $531,600 | $734,800 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $35,100 | $-67,700 | $101,900 | $49,600 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $1,049,900 | $2,375,000 | $3,008,500 | $3,792,900 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $1,161,500 | $1,632,200 | $1,292,900 | $1,371,900 |
| Payments to Acquire Property, Plant, and Equipment | $277,000 | $153,700 | $153,800 | $167,900 |
| Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | $7,380,800 | $0 | $23,000 | $648,200 |
| Payments to Acquire Debt Securities, Available-for-sale | $5,140,700 | $0 | $1,258,300 | $2,007,100 |
| Payments to Acquire Businesses, Net of Cash Acquired | $6,926,100 | $1,074,800 | — | $0 |
| Proceeds from Divestiture of Interest in Consolidated Subsidiaries | $788,100 | $406,800 | $0 | $0 |
| Proceeds from Sale of Property, Plant, and Equipment | $0 | $88,600 | $0 | $0 |
| Payments to Acquire in Process Research and Development | $18,000 | — | $50,000 | $85,000 |
| Payments to Acquire Intangible Assets | $34,400 | $206,100 | $31,600 | $21,600 |
| Proceeds from Sale of Equity Method Investments | $119,600 | $144,700 | $56,700 | $56,700 |
| Payments for (Proceeds from) Other Investing Activities | $11,300 | $4,700 | $-42,900 | $-42,900 |
| Net Cash Provided by (Used in) Investing Activities | $-4,101,000 | $-799,200 | $-1,371,100 | $-1,533,300 |
| Payment, Tax Withholding, Share-based Payment Arrangement | $44,300 | $31,300 | $10,000 | $40,800 |
| Proceeds from Issuance of Long-term Debt | $997,200 | $0 | $1,733,100 | $1,733,100 |
| Repayments of Long-term Debt | — | — | $1,750,000 | $1,750,000 |
| Proceeds from (Payments to) Noncontrolling Interests | $12,300 | $0 | $0 | $0 |
| Payment for Contingent Consideration Liability, Financing Activities | — | — | $280,000 | $280,000 |
| Proceeds from (Payments for) Other Financing Activities | $-6,000 | $-2,200 | $5,000 | $15,000 |
| Net Cash Provided by (Used in) Financing Activities | $149,300 | $-683,500 | $-301,900 | $-322,700 |
| Depreciation, Depletion and Amortization | $494,800 | $673,200 | $779,900 | $801,100 |
| Impairment of Intangible Assets (Excluding Goodwill) | $0 | $60,200 | $7,900 | $7,900 |
| Operating Lease, Impairment Loss | — | — | $52,900 | $52,900 |
| Inventory Write-down | $124,400 | $101,900 | $29,200 | $26,700 |
| Research and Development Asset Acquired Other than Through Business Combination, Written-off | — | — | $85,000 | $85,000 |
| Share-based Payment Arrangement, Noncash Expense | $264,200 | $291,200 | $290,800 | $293,800 |
| Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings | $0 | $-27,700 | $-33,600 | $-22,700 |
| Deferred Income Tax Expense (Benefit) | $-305,800 | $-158,100 | $361,600 | $413,000 |
| Increase (Decrease) in Equity Securities, FV-NI | $-277,100 | $-101,400 | $-19,300 | $40,600 |
| Gain (Loss) on Disposition of Intangible Assets | — | $88,600 | $0 | $0 |
| Other Noncash Income (Expense) | $-148,200 | $-159,600 | $-68,300 | $-89,600 |
| Net Cash Provided by (Used in) Operating Activities | $1,547,200 | $2,875,500 | $2,204,600 | $2,590,800 |
| Increase (Decrease) in Accounts Receivable | $-61,300 | $-222,300 | $-102,700 | $-102,700 |
| Increase (Decrease) in Other Operating Assets and Liabilities, Net | $4,600 | $28,100 | $60,600 | $96,100 |
| Increase (Decrease) in Inventories | $130,900 | $273,800 | $64,700 | $10,500 |
| Increase (Decrease) in Accrued Liabilities | $-201,600 | $24,600 | $171,100 | $228,400 |
| Increase (Decrease) in Income Taxes Payable | $-299,000 | $78,500 | $-958,100 | $-1,008,800 |
| Increase (Decrease) in Other Operating Liabilities | $-73,900 | $-178,700 | $-248,000 | $-248,000 |